Latest Research & News

Resource Trader Subscription Alert
Most traders are starting to price in another leg down.
Weiss Investor Signals Subscription Your Issue
A healthy dose of drug stocks has turned out to be a great investment prescription.
In this segment, Investment Analyst Nilus Mattive discusses strategies like tax-loss harvesting to help you these last few weeks of 2022.
Strategic Options Subscription
In 2022, investors have contended with a messy war in Eastern Europe, worldwide inflation and supply chain bottlenecks. It’s been a tough slog, yet there are better times ahead. The world is...
Weiss Crypto Portfolio Subscription Your Issue
We’re still on the lookout for bottom confirmation signals, but we will soon start preparing our portfolio for our next move.
Despite the mixed performance across the broad crypto market, this sector is making a strong showing.
While this week might not be as exciting as last, we’ve got one very important piece of economic data on Friday.
Strategic Options Subscription Alert
Stocks are kicking off the week with losses and bond yields climbed as a U.S. services gauge rose unexpectedly.
Safe Money Report Subscription Your Issue
This week, I have the pleasure of sitting down with Kenny Polcari, host of Wealth & Wisdom, who interviews those in the know.
Safe Money Report Subscription Your Issue
Today, I’m talking to Nilus Mattive, associate editor of Safe Money Report.
Top Cryptocurrencies
See All »
B
BTC $59,806.00
B
B
ETH $1,608.79
Top Tech Stocks
See All »
B
NVDA NASDAQ $195.63
B
AAPL NASDAQ $294.92
B
AVGO NASDAQ $369.90
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $107.65
Top Financial Stocks
See All »
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $1,192.04
B
JNJ NYSE $253.32
B
AMGN NASDAQ $362.45
Top Real Estate Stocks
See All »
B
PLD NYSE $136.45